Cargando…
Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
The mechanisms underlying the neuroprotective effects of the hybrid antioxidant-nitric oxide donating compound SA-2 in retinal ganglion cell (RGC) degeneration models were evaluated. The in vitro trophic factor (TF) deprivation model in primary rat RGCs and ex vivo human retinal explants were used t...
Autores principales: | Pham, Jennifer H., Johnson, Gretchen A., Rangan, Rajiv S., Amankwa, Charles E., Acharya, Suchismita, Stankowska, Dorota L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735605/ https://www.ncbi.nlm.nih.gov/pubmed/36497005 http://dx.doi.org/10.3390/cells11233741 |
Ejemplares similares
-
Modulation of Mitochondrial Metabolic Parameters and Antioxidant Enzymes in Healthy and Glaucomatous Trabecular Meshwork Cells with Hybrid Small Molecule SA-2
por: Amankwa, Charles E., et al.
Publicado: (2023) -
Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure–lowering activity in rodent eyes
por: Stankowska, Dorota L., et al.
Publicado: (2021) -
Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
por: Nam, Mi-Hyun, et al.
Publicado: (2022) -
Mitochondria-associated endoplasmic reticulum membranes (MAMs) and their role in glaucomatous retinal ganglion cell degeneration—a mini review
por: Pham, Jennifer H., et al.
Publicado: (2023) -
Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)